Nokia Corp. Stock
€12.44
Your prediction
Nokia Corp. Stock
Pros and Cons of Nokia Corp. in the next few years
Pros
Cons
Performance of Nokia Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nokia Corp. | -12.480% | -2.356% | 8.319% | 164.462% | 122.451% | 225.907% | 175.111% |
| Nokia Corp. A ADR | -13.890% | -2.344% | 8.696% | 164.831% | 121.239% | 228.947% | 176.549% |
| Fortive Corp | 0.080% | 3.222% | 2.466% | -15.210% | 11.418% | -14.858% | -11.895% |
| Infineon Technologies ADR | -6.430% | -0.621% | 33.333% | 127.273% | 116.216% | 131.214% | 142.424% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first impression, the financials of Nokia (US symbol: NOKBF), a prominent player in the Computers, Phones & Household Electronics industry, display a mixed outlook. While the company has experienced steady growth in total assets and stockholder equity, it also exhibits volatile cash flows and net income throughout the analyzed periods. Further examination of Nokia's financials will facilitate a better understanding of the company's position and potential trajectory.
*Pros: *
Growth in Total Assets: Over the years, Nokia's total assets have been on the rise, from €36,191,000,000 in 2020 to €42,943,000,000 in 2022. This growth indicates that the company is expanding and investing in its operations, which can contribute to its long-term success.
Comments
News
Insiders Are Buying This Nvidia-Backed $15 Stock Hand Over Fist. Should You?
Long known for mobile brick phones and traditional telecom infrastructure, Nokia (NYSE: NOK) is quietly in the middle of an exciting transformation. Back in October, Nvidia (NASDAQ: NVDA) made a $1
Grundium Acquires Visiopharm to Create Integrated Precision Pathology Platform
The combined platform brings together digital slide scanning and AI-driven precision pathology software to accelerate accessible and scalable adoption of precision diagnostics
TAMPERE, FI
Ceragon Networks Q1 Earnings Call Highlights
Key Points
- Interested in Ceragon Networks Ltd.? Here are five stocks we like better.
- Ceragon posted a solid Q1 with revenue of $85 million and non-GAAP EPS of $0.01, while management
